morepen-laboratories-ltd
Home
Morepen Laboratories Ltd
MOREPENLAB Share Price
BSE:
NSE:MOREPENLAB
MOREPENLAB Share Price
BSE:
NSE:MOREPENLAB
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹4,773.77 Cr
PE Ratio
36.30
Morepen Laboratories Ltd Performance
▲
▲
▲
▲
Morepen Laboratories Ltd Fundamentals
Morepen Laboratories Ltd Delivery and Volume
About Morepen Laboratories Ltd
Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesi
Name | Designation |
---|---|
Sushil Suri | Chairman & Managing Director |
Vipul Kumar Srivatava | Company Sec. & Compli. Officer |
Sanjay Suri | Whole-time Director |
Praveen Kumar Dutt | Non-Exec. & Independent Dir. |
Savita | Non-Exec. & Independent Dir. |
Sharad Jain | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Morepen Laboratories Ltd FAQs
How do I Buy Morepen Laboratories Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Morepen Laboratories Ltd shares in BlinkX.
What is the Share Price of Morepen Laboratories Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Morepen Laboratories Ltd's share price is ₹87.13 as of 2024-12-13.
What is the PE ratio of Morepen Laboratories Ltd?
Morepen Laboratories Ltd's P/E ratio is 36.3 times as of 2024-12-13.
What is the PB ratio of Morepen Laboratories Ltd?
Morepen Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 4.3, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Morepen Laboratories Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Morepen Laboratories Ltd's market capitalization is ₹4773.77 Cr as on 2024-12-13.
What is the ROE of Morepen Laboratories Ltd?
The current financial records of Morepen Laboratories Ltd show a 13.29% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Morepen Laboratories Ltd?
According to Morepen Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹853.29, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Morepen Laboratories Ltd?
The 52-week high/low price of a Morepen Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Morepen Laboratories Ltd's 52-week high and low as of 2024-12-13 are ₹88.7 and ₹84.7, respectively.